Diane Parks

Insider Reports History

Entity
Individual
Location
29 Emmons Drive, Suite B 10, Princeton, NJ
Signature
/s/ Teresa Bair, Attorney-in-fact for Diane Parks
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Diane Parks:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Celularity Inc Director Class A Common Stock 236K $58.8K $0.25 Jun 14, 2023 Direct
Celularity Inc Director Stock Option (Right to Buy) 278K Jun 14, 2023 Direct
SOLIGENIX, INC. Director Stock Option (Right to Buy) 38.1K Dec 15, 2023 Direct
Kura Oncology, Inc. Director Option to purchase common stock 26K Jun 5, 2024 Direct
CTI BIOPHARMA CORP Director Stock Option (Right to Buy) 0 Jun 26, 2023 Direct

Insider Reports Filed by Diane Parks

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KURA Kura Oncology, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
SNGX SOLIGENIX, INC. Dec 15, 2023 1 $0 4 Dec 15, 2023 Director
CTIC CTI BIOPHARMA CORP Jun 26, 2023 3 $0 4 Jun 26, 2023 Director
CELU Celularity Inc Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
KURA Kura Oncology, Inc. May 31, 2023 1 $0 4 Jun 2, 2023 Director
CTIC CTI BIOPHARMA CORP Apr 5, 2023 1 $0 4 Apr 7, 2023 Director
SNGX SOLIGENIX, INC. Nov 17, 2022 1 $0 4 Nov 21, 2022 Director
CELU Celularity Inc Jul 13, 2022 2 $0 4 Jul 15, 2022 Director
KURA Kura Oncology, Inc. Jun 21, 2022 1 $0 4 Jun 23, 2022 Director
CELU Celularity Inc Jun 2, 2022 1 $0 4 Jun 3, 2022 Director
CELU Celularity Inc Jun 2, 2022 0 $0 3 Jun 3, 2022 Director
CTIC CTI BIOPHARMA CORP Mar 9, 2022 1 $0 4 Mar 11, 2022 Director
SNGX SOLIGENIX, INC. Sep 23, 2021 1 $0 4 Sep 24, 2021 Director
CTIC CTI BIOPHARMA CORP Aug 24, 2021 0 $0 3 Sep 3, 2021 Director
KURA Kura Oncology, Inc. Jun 22, 2021 1 $0 4 Jun 23, 2021 Director